ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078 | +136.4% | 682 | +223.2% | 0.00% | – |
| Q2 2023 | $456 | +15100.0% | 211 | -83.5% | 0.00% | – |
| Q1 2023 | $3 | -92.1% | 1,281 | -92.7% | 0.00% | -100.0% |
| Q4 2022 | $38 | -100.0% | 17,443 | -57.4% | 0.00% | 0.0% |
| Q3 2022 | $123,000 | +98.4% | 40,965 | +87.8% | 0.00% | +100.0% |
| Q2 2022 | $62,000 | +1140.0% | 21,815 | +2032.5% | 0.00% | – |
| Q1 2022 | $5,000 | – | 1,023 | +3992.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 25 | -96.3% | 0.00% | – |
| Q3 2021 | $6,000 | +500.0% | 681 | +262.2% | 0.00% | – |
| Q2 2021 | $1,000 | -98.5% | 188 | -98.8% | 0.00% | -100.0% |
| Q1 2021 | $68,000 | +518.2% | 15,251 | +437.4% | 0.00% | – |
| Q4 2020 | $11,000 | +175.0% | 2,838 | +178.5% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 1,019 | -43.6% | 0.00% | -100.0% |
| Q4 2019 | $8,000 | -61.9% | 1,806 | -69.8% | 0.00% | 0.0% |
| Q3 2019 | $21,000 | – | 5,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |